Literature DB >> 15764489

The chemopreventive effects of orally administered dexamethasone in Strain A/J mice following cessation of smoke exposure.

Hanspeter Witschi1, Imelda Espiritu, Man Ly, Dale Uyeminami.   

Abstract

Male Strain A/J mice were exposed for 6 mo, 6 h/d, 5d/wk to a mixture of cigarette sidestream and mainstream smoke with an average total suspended particulate concentration of 156 mg/m3. They then were removed into air and fed diet AIN93M containing 0.5 mg/kg of dexamethasone until killed 4 mo later for the evaluation of lung tumor multiplicities. In animals kept in air, an average of 1.3 tumors per lung was found, and in tobacco-smoke-exposed animals the average number of tumors per lung was 2.2 (p<.05). Addition of dexamethasone to the diet reduced lung tumor multiplicities in the tobacco smoke exposed animals to 1.4 (64% of control values), not quite statistically significant. In animals not exposed to tobacco smoke, however, dexamethasone significantly decreased lung tumor multiplicities to 46% of control values. In animals injected with the tobacco-smoke-specific carcinogen NNK [4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone], dietary dexamethasone significantly reduced lung tumor multiplicities to 38% of controls. It is concluded that the dietary intake of dexamethasone against full tobacco smoke might show improved chemopreventive activity when combined with other agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764489     DOI: 10.1080/08958370590899712

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  10 in total

1.  Anti-Inflammatory Agents for Cancer Therapy.

Authors:  Elizabeth R Rayburn; Scharri J Ezell; Ruiwen Zhang
Journal:  Mol Cell Pharmacol       Date:  2009

2.  Resolvin E1 Reduces Tumor Growth in a Xenograft Model of Lung Cancer.

Authors:  Alpdogan Kantarci; Shevali Kansal; Hatice Hasturk; Danielle Stephens; Thomas E Van Dyke
Journal:  Am J Pathol       Date:  2022-08-06       Impact factor: 5.770

3.  Nr1d1, an important circadian pathway regulatory gene, is suppressed by cigarette smoke in murine lungs.

Authors:  Vihas T Vasu; Carroll E Cross; Kishorchandra Gohil
Journal:  Integr Cancer Ther       Date:  2009-11-18       Impact factor: 3.279

Review 4.  Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers.

Authors:  Stephen S Hecht; Fekadu Kassie; Dorothy K Hatsukami
Journal:  Nat Rev Cancer       Date:  2009-07       Impact factor: 60.716

5.  Pathogenic mechanism of second hand smoke induced inflammation and COPD.

Authors:  Rahel L Birru; Y Peter Di
Journal:  Front Physiol       Date:  2012-08-28       Impact factor: 4.566

6.  Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor.

Authors:  Lisa Rice; Charlotte E Waters; Jennifer Eccles; Helen Garside; Paula Sommer; Paul Kay; Fiona H Blackhall; Leo Zeef; Brian Telfer; Ian Stratford; Rob Clarke; Dave Singh; Adam Stevens; Anne White; David W Ray
Journal:  J Endocrinol       Date:  2008-06-26       Impact factor: 4.286

Review 7.  Targeting Inflammation in Cancer Prevention and Therapy.

Authors:  Jelena Todoric; Laura Antonucci; Michael Karin
Journal:  Cancer Prev Res (Phila)       Date:  2016-11-10

8.  Lung inflammatory effects, tumorigenesis, and emphysema development in a long-term inhalation study with cigarette mainstream smoke in mice.

Authors:  Walter Stinn; Ansgar Buettner; Horst Weiler; Baerbel Friedrichs; Sonja Luetjen; Frans van Overveld; Kris Meurrens; Kris Janssens; Stephan Gebel; Regina Stabbert; Hans-Juergen Haussmann
Journal:  Toxicol Sci       Date:  2012-10-26       Impact factor: 4.849

9.  The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution.

Authors:  Gui-Zhen Wang; Xin Cheng; Bo Zhou; Zhe-Sheng Wen; Yun-Chao Huang; Hao-Bin Chen; Gao-Feng Li; Zhi-Liang Huang; Yong-Chun Zhou; Lin Feng; Ming-Ming Wei; Li-Wei Qu; Yi Cao; Guang-Biao Zhou
Journal:  Elife       Date:  2015-11-13       Impact factor: 8.140

Review 10.  Anti-Inflammatory Drugs as Anticancer Agents.

Authors:  Silvia Zappavigna; Alessia Maria Cossu; Anna Grimaldi; Marco Bocchetti; Giuseppe Andrea Ferraro; Giovanni Francesco Nicoletti; Rosanna Filosa; Michele Caraglia
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.